BCTX
BriaCell Therapeutics Corp

10,090
Loading...
Loading...
News
all
press releases
All You Need to Know About BRIACELL THERAP (BCTX) Rating Upgrade to Buy
BRIACELL THERAP (BCTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·23d ago
News Placeholder
More News
News Placeholder
BriaCell Stock Dips After-Hours On Pricing $13.8M Public Offering, But Retail's Busy Cheering Clinical Milestone
Earlier on Thursday, BriaCell said that a patient in its Phase 1/2a Bria-OTS trial continues to show a complete resolution of lung metastasis.
Stocktwits·5mo ago
News Placeholder
BriaCell Stock Rises On Positive Survival Data From Study In Cancer Patients: Retail Gets More Bullish
HR+ metastatic breast cancer patients treated with Bria-IMT plus check point inhibitors had a median overall survival of 17.3 months, exceeding the 14.4 months with Trodelvy in similar heavily pre-treated patients, the company said.
Stocktwits·6mo ago
News Placeholder
BriaCell Stock Climbs After ‘Unprecedented’ Immunotherapy Response In Breast Cancer Patient, Retail Exudes Optimism
Bria-OTS is a next-generation, personalized advancement of BriaCell’s lead candidate, Bria-IMT, which is currently in a pivotal Phase 3 study for metastatic breast cancer.
Stocktwits·8mo ago
News Placeholder
News Movers: Yesterday’s Hottest News That Could Move the Needle Today
Your Only Digest of Market-Moving News and Rumours From High-Growth, Small Cap Stocks
Stocktwits Contributor·10mo ago
News Placeholder
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend PR Newswire VANCOUVER, BC, Dec. 2, 2024 USA...
PR Newswire·10mo ago
News Placeholder
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint...
Benzinga·1y ago
News Placeholder
Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTX) Drops By 7.9%
BriaCell Therapeutics Corp. (NASDAQ:BCTX - Get Free Report) was the recipient of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling...
Ticker Report·2y ago
News Placeholder
BriaCell Partners to Propel Cancer Vaccine Development
BriaCell Therapeutics (TSE:BCT) has released an update. BriaCell Therapeutics has entered a significant agreement with the University of Texas MD A...
TipRanks Financial Blog·2y ago
News Placeholder
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate cancer), BriaCell's novel off-the-shelf personalized cancer...
Globe Newswire·2y ago

Latest BCTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.